KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Msci (MSCI) Research & Development (2016 - 2025)

Msci (MSCI) has disclosed Research & Development for 12 consecutive years, with $41.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development rose 6.9% year-over-year to $41.1 million, compared with a TTM value of $177.6 million through Dec 2025, up 11.94%, and an annual FY2025 reading of $177.6 million, up 11.94% over the prior year.
  • Research & Development was $41.1 million for Q4 2025 at Msci, down from $44.8 million in the prior quarter.
  • Across five years, Research & Development topped out at $47.6 million in Q1 2025 and bottomed at $23.9 million in Q2 2022.
  • Average Research & Development over 5 years is $34.4 million, with a median of $31.4 million recorded in 2023.
  • The sharpest move saw Research & Development decreased 13.13% in 2022, then soared 36.27% in 2024.
  • Year by year, Research & Development stood at $30.8 million in 2021, then fell by 5.82% to $29.0 million in 2022, then soared by 35.12% to $39.2 million in 2023, then fell by 1.91% to $38.5 million in 2024, then grew by 6.9% to $41.1 million in 2025.
  • Business Quant data shows Research & Development for MSCI at $41.1 million in Q4 2025, $44.8 million in Q3 2025, and $44.1 million in Q2 2025.